What is the risk of splenic rupture associated with Calquence (acalabrutinib)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Splenic rupture is a rare adverse event associated with Calquence (acalabrutinib). However, the provided evidence does not directly address the risk of splenic rupture associated with Calquence (acalabrutinib) [ 1 ].

  • The evidence discusses splenic abscess and infarction in the context of infective endocarditis, which is a different condition [ 1 ].
  • It highlights the importance of monitoring for signs and symptoms of splenic complications, such as abdominal pain and tenderness, in patients with certain medical conditions [ 1 ].
  • Although the evidence does not provide specific information on the risk of splenic rupture associated with Calquence (acalabrutinib), it is essential to monitor patients receiving this medication for any signs of splenic complications.
  • Prompt medical attention should be sought if splenic rupture is suspected, as it can be a life-threatening condition.
  • The evidence suggests that imaging studies, such as abdominal CT and MRI, can be useful in diagnosing splenic complications [ 1 ].

From the Research

Risk of Splenic Rupture

The risk of splenic rupture associated with Calquence (acalabrutinib) is not directly addressed in the provided studies. However, the studies discuss the risk of splenic rupture in various contexts:

  • Spontaneous splenic rupture is a rare and life-threatening condition that can occur in patients with underlying pathological conditions, such as hematologic malignancies 2, 3.
  • Atraumatic idiopathic splenic rupture can be induced by granulocyte-colony stimulating factor (G-CSF) administration 4.
  • Splenic rupture can occur in patients with infectious mononucleosis, although this is a rare complication 5.
  • Delayed splenic rupture is a rare complication of non-operative management of primary splenic trauma, and can occur months after the initial injury 6.

Key Points

  • The provided studies do not specifically mention Calquence (acalabrutinib) as a risk factor for splenic rupture.
  • Splenic rupture is a potentially life-threatening condition that requires prompt diagnosis and treatment.
  • The risk of splenic rupture is associated with various underlying conditions, including hematologic malignancies, G-CSF administration, and infectious mononucleosis.
  • Delayed splenic rupture is a rare complication of non-operative management of primary splenic trauma.

Symptoms and Diagnosis

  • The most common symptom of spontaneous splenic rupture is acute abdominal pain, which can radiate to the left shoulder 2, 5.
  • Diagnostic methods of choice for splenic rupture include computed tomography and ultrasound 2, 3.
  • Laboratory results may indicate low hemoglobin and hematocrit levels, as well as other abnormalities 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.